Response Genetics, Inc
RGDXQ
$0.00
$0.000.00%
OTC PK
| 03/31/2015 | 12/31/2014 | 09/30/2014 | 06/30/2014 | 03/31/2014 | |
|---|---|---|---|---|---|
| Revenue | -2.68% | -14.50% | 9.11% | -19.43% | -30.75% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.68% | -14.50% | 9.11% | -19.43% | -30.75% |
| Cost of Revenue | -5.08% | 18.21% | -7.20% | -4.52% | -3.76% |
| Gross Profit | 1.33% | -49.74% | 42.17% | -34.94% | -52.87% |
| SG&A Expenses | 8.55% | -11.79% | 29.79% | 26.19% | 24.86% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.80% | -3.73% | 14.49% | 12.18% | 15.05% |
| Operating Income | -4.69% | -12.57% | -22.55% | -144.15% | -343.48% |
| Income Before Tax | -14.67% | -7.27% | -34.06% | -141.98% | -325.14% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -14.67% | -7.27% | -34.06% | -141.98% | -325.14% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.67% | -7.27% | -34.06% | -141.98% | -325.14% |
| EBIT | -4.69% | -12.57% | -22.55% | -144.15% | -343.48% |
| EBITDA | -5.44% | -12.96% | -22.31% | -157.02% | -405.71% |
| EPS Basic | -14.48% | 0.34% | -14.76% | -105.06% | -260.56% |
| Normalized Basic EPS | -14.31% | -13.59% | -14.62% | -105.26% | -260.51% |
| EPS Diluted | -14.48% | 0.34% | -14.76% | -105.06% | -260.56% |
| Normalized Diluted EPS | -14.31% | -13.59% | -14.62% | -105.26% | -260.51% |
| Average Basic Shares Outstanding | 0.20% | 7.63% | 16.89% | 18.10% | 18.05% |
| Average Diluted Shares Outstanding | 0.20% | 7.63% | 16.89% | 18.10% | 18.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |